Algorithmic Trading

This algorithmic trading forecast is designed for investors and analysts who need predictions of the best performing stocks for the whole Biotechnology Industry (See Industry Package). It includes 20 stocks with bullish and bearish signals and indicates the best biotech stocks to buy:

• Top 10 biotech stocks for the long position
• Top 10 biotech stocks for the short position

Package Name: BioTech Stocks
Forecast Length: 3 Months (02/28/16– 05/28/16)
I Know First Average: 29.88%

The algorithm correctly predicted 9 out of the 10 stocks forecasted to increase during the predicted time horizon of 3 Months in the bioTech-stocks package forecast from 02/28/2016. The most impressive prediction was for MDVN, which registered a return of 70.45% during the predicted time horizon. Other impressive returns came from KERX and ARIA which increased by 60.99% and 54.61%, respectively. The average return from this forecast for investors was 29.88%, offering a premium to investors over the S&P 500 return of 7.75% during the predicted time horizon.

Medivation, Inc. (MDVN), a biopharmaceutical company, focuses on the development and commercialization of medical therapies to treat serious diseases in the United States. It offers XTANDI for the treatment of post-chemotherapy metastatic castration-resistant prostate cancer (CRPC) patients.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First algorithmic traders.

How to interpret this diagram

Please, note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.